Integrated Diagnostics (LON:IDHC) Stock Price Down 11.9% – Here’s What Happened

Integrated Diagnostics Holdings plc (LON:IDHC) was down 11.9% during mid-day trading on Tuesday . The company traded as low as GBX 0.49 and last traded at GBX 0.50. Approximately 953,582 shares changed hands during mid-day trading, an increase of 436% from the average session volume of 177,907 shares. The stock had previously closed at GBX 0.56.

Integrated Diagnostics Trading Down 11.9%

The company has a market cap of £2.88 million, a price-to-earnings ratio of 0.00, a price-to-earnings-growth ratio of 7.65 and a beta of 0.38. The company’s 50 day moving average price is GBX 0.59 and its 200 day moving average price is GBX 0.62. The company has a debt-to-equity ratio of 43.40, a quick ratio of 0.75 and a current ratio of 1.53.

Integrated Diagnostics Company Profile

IDH is a leading diagnostics services provider in the Middle East and Africa offering a broad range of clinical pathology and
radiology tests to patients in Egypt, Jordan, Nigeria, Saudi Arabia, and Sudan. The Group’s core brands include Al Borg, Al Borg
Scan and Al Mokhtabar in Egypt, as well as Biolab (Jordan), Echo-Lab (Nigeria), Ultralab and Al Mokhtabar Sudan (both in Sudan),
and Biolab KSA (Saudi Arabia). With over 40 years of experience, a long track record for quality and safety has earned the Company
a trusted reputation, as well as internationally recognised accreditations for its portfolio of over 3,000 diagnostics tests.